Published in Womens Health (Lond Engl) on March 01, 2010
Sex bias in trials and treatment must end. Nature (2010) 2.28
Frontiers: Integration of a Research Participant Registry with Medical Clinic Registration and Electronic Health Records. Clin Transl Sci (2015) 0.76
Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results From the Women's Health Initiative randomized controlled trial. JAMA (2002) 80.37
A randomized trial of low-dose aspirin in the primary prevention of cardiovascular disease in women. N Engl J Med (2005) 17.32
Underrepresentation of patients 65 years of age or older in cancer-treatment trials. N Engl J Med (1999) 11.44
Sex differences in HIV-1 viral load and progression to AIDS. Lancet (1998) 5.24
Sex differences in autoimmune disease. Nat Immunol (2001) 5.08
Recruitment and retention of minority women in cancer screening, prevention, and treatment trials. Ann Epidemiol (2000) 3.33
Women subjects in NIH-funded clinical research literature: lack of progress in both representation and analysis by sex. J Womens Health Gend Based Med (2000) 2.89
Tracking women's awareness of heart disease: an American Heart Association national study. Circulation (2004) 2.37
Involving minority and underrepresented women in clinical trials: the National Centers of Excellence in Women's Health. J Womens Health Gend Based Med (2000) 2.01
Adherence to federal guidelines for reporting of sex and race/ethnicity in clinical trials. J Womens Health (Larchmt) (2006) 1.97
Gender effects in pharmacokinetics and pharmacodynamics. Drugs (1995) 1.94
Women's health and women's leadership in academic medicine: hitting the same glass ceiling? J Womens Health (Larchmt) (2008) 1.91
Impact of body weight on blood pressure with a focus on sex differences: the Tromso Study, 1986-1995. Arch Intern Med (2000) 1.41
Status of women in cardiovascular clinical trials. Arterioscler Thromb Vasc Biol (2009) 1.41
Epidemiology of depression throughout the female life cycle. J Clin Psychiatry (2002) 1.33
Sex differences in perceived risks, distrust, and willingness to participate in clinical trials: a randomized study of cardiovascular prevention trials. Arch Intern Med (2007) 1.12
Biologic and molecular mechanisms for sex differences in pharmacokinetics, pharmacodynamics, and pharmacogenetics: Part II. J Womens Health Gend Based Med (2002) 1.10
Pain sensations to the cold pressor test in normally menstruating women: comparison with men and relation to menstrual phase and serum sex steroid levels. Am J Physiol Regul Integr Comp Physiol (2007) 1.06
Sex differences in presentation, management, and prognosis of patients with non-small cell lung carcinoma. J Thorac Cardiovasc Surg (2000) 1.05
Recruitment of women research participants: the Women's Health Registry at the University of Michigan. J Womens Health (Larchmt) (2007) 1.04
Minorities, women, and clinical cancer research: the charge, promise, and challenge. Ann Epidemiol (2000) 1.02
Physiological changes during the menstrual cycle and their effects on the pharmacokinetics and pharmacodynamics of drugs. Clin Pharmacokinet (1998) 0.96
Preservation of fertility in patients with cancer. N Engl J Med (2009) 7.11
The time is now for a new approach to primary ovarian insufficiency. Fertil Steril (2010) 3.15
Cancer survivors and infertility: a review of a new problem and novel answers. J Support Oncol (2006) 3.01
Tissue-engineered follicles produce live, fertile offspring. Tissue Eng (2006) 2.87
Sex bias in trials and treatment must end. Nature (2010) 2.28
Postnatal regulation of germ cells by activin: the establishment of the initial follicle pool. Dev Biol (2006) 1.85
Identification of a stage-specific permissive in vitro culture environment for follicle growth and oocyte development. Biol Reprod (2006) 1.83
Zinc availability regulates exit from meiosis in maturing mammalian oocytes. Nat Chem Biol (2010) 1.76
In vitro grown human ovarian follicles from cancer patients support oocyte growth. Hum Reprod (2009) 1.71
The possible role of resource requirements and academic career-choice risk on gender differences in publication rate and impact. PLoS One (2012) 1.69
Regulation of mouse follicle development by follicle-stimulating hormone in a three-dimensional in vitro culture system is dependent on follicle stage and dose. Biol Reprod (2005) 1.67
Physical properties of alginate hydrogels and their effects on in vitro follicle development. Biomaterials (2007) 1.66
The in vitro regulation of ovarian follicle development using alginate-extracellular matrix gels. Biomaterials (2005) 1.63
The structure of the follistatin:activin complex reveals antagonism of both type I and type II receptor binding. Dev Cell (2005) 1.63
Encapsulated three-dimensional culture supports development of nonhuman primate secondary follicles. Biol Reprod (2009) 1.62
Female reproductive disorders: the roles of endocrine-disrupting compounds and developmental timing. Fertil Steril (2008) 1.60
Novel approach for the three-dimensional culture of granulosa cell-oocyte complexes. Tissue Eng (2003) 1.60
Fertility preservation and adolescent cancer patients: lessons from adult survivors of childhood cancer and their parents. Cancer Treat Res (2007) 1.59
Ovarian epithelial inclusion cysts in chronically superovulated CD1 and Smad2 dominant-negative mice. Endocrinology (2007) 1.51
Fate of the initial follicle pool: empirical and mathematical evidence supporting its sufficiency for adult fertility. Dev Biol (2006) 1.49
Induction of cyclin D2 in rat granulosa cells requires FSH-dependent relief from FOXO1 repression coupled with positive signals from Smad. J Biol Chem (2004) 1.48
Structures of an ActRIIB:activin A complex reveal a novel binding mode for TGF-beta ligand:receptor interactions. EMBO J (2003) 1.46
Interpenetrating fibrin-alginate matrices for in vitro ovarian follicle development. Biomaterials (2009) 1.46
Activin A mediates growth inhibition and cell cycle arrest through Smads in human breast cancer cells. Cancer Res (2005) 1.42
The primordial pool of follicles and nest breakdown in mammalian ovaries. Mol Hum Reprod (2009) 1.41
Regulation of the rat follicle-stimulating hormone beta-subunit promoter by activin. Mol Endocrinol (2002) 1.38
Zinc sparks are triggered by fertilization and facilitate cell cycle resumption in mammalian eggs. ACS Chem Biol (2011) 1.37
Transforming growth factor-beta1, transforming growth factor-beta2, and transforming growth factor-beta3 enhance ovarian cancer metastatic potential by inducing a Smad3-dependent epithelial-to-mesenchymal transition. Mol Cancer Res (2008) 1.27
Secondary follicle growth and oocyte maturation by culture in alginate hydrogel following cryopreservation of the ovary or individual follicles. Biotechnol Bioeng (2009) 1.27
Engineering the follicle microenvironment. Semin Reprod Med (2007) 1.24
Chromosome cohesion decreases in human eggs with advanced maternal age. Aging Cell (2012) 1.24
The mouse follicle microenvironment regulates antrum formation and steroid production: alterations in gene expression profiles. Biol Reprod (2008) 1.23
The regulatory role of Dicer in folliculogenesis in mice. Mol Cell Endocrinol (2009) 1.20
In vitro oocyte maturation and preantral follicle culture from the luteal-phase baboon ovary produce mature oocytes. Biol Reprod (2010) 1.20
Evidence for chromosome 2p16.3 polycystic ovary syndrome susceptibility locus in affected women of European ancestry. J Clin Endocrinol Metab (2012) 1.19
Down-regulation of activin, activin receptors, and Smads in high-grade breast cancer. Cancer Res (2003) 1.19
An estrogen receptor-alpha knock-in mutation provides evidence of ligand-independent signaling and allows modulation of ligand-induced pathways in vivo. Endocrinology (2008) 1.16
A novel two-step strategy for in vitro culture of early-stage ovarian follicles in the mouse. Fertil Steril (2009) 1.15
Results from the survey for preservation of adolescent reproduction (SPARE) study: gender disparity in delivery of fertility preservation message to adolescents with cancer. J Assist Reprod Genet (2010) 1.15
Suppression of Notch signaling in the neonatal mouse ovary decreases primordial follicle formation. Endocrinology (2008) 1.14
Repropedia: a reproductive lexicon to fill the gap in reproductive terminology. Biol Reprod (2012) 1.14
Adoption after cancer: adoption agency attitudes and perspectives on the potential to parent post-cancer. Cancer Treat Res (2010) 1.12
Neonatal exposure to estrogens suppresses activin expression and signaling in the mouse ovary. Endocrinology (2007) 1.11
Smad3 mediates activin-induced transcription of follicle-stimulating hormone beta-subunit gene. Mol Endocrinol (2005) 1.10
Zinc requirement during meiosis I-meiosis II transition in mouse oocytes is independent of the MOS-MAPK pathway. Biol Reprod (2010) 1.10
Distribution of extracellular matrix proteins type I collagen, type IV collagen, fibronectin, and laminin in mouse folliculogenesis. Histochem Cell Biol (2006) 1.10
Roles for transforming growth factor beta superfamily proteins in early folliculogenesis. Semin Reprod Med (2009) 1.07
Gonadotropin-induced superovulation drives ovarian surface epithelia proliferation in CD1 mice. Endocrinology (2006) 1.07
Extracellular matrix functions in follicle maturation. Semin Reprod Med (2006) 1.07
Ovarian follicle development requires Smad3. Mol Endocrinol (2004) 1.06
Medical hope, legal pitfalls: potential legal issues in the emerging field of oncofertility. Cancer Treat Res (2010) 1.06
Prepubertal primordial follicle loss in mice is not due to classical apoptotic pathways. Biol Reprod (2009) 1.06
The structural basis of TGF-beta, bone morphogenetic protein, and activin ligand binding. Reproduction (2006) 1.06
Age-related analysis of inhibin A, inhibin B, and activin a relative to the intercycle monotropic follicle-stimulating hormone rise in normal ovulatory women. J Clin Endocrinol Metab (2004) 1.05
Preserving female fertility following cancer treatment: current options and future possibilities. Pediatr Blood Cancer (2009) 1.04
Activin regulates estrogen receptor gene expression in the mouse ovary. J Biol Chem (2007) 1.04
A zinc-dependent mechanism regulates meiotic progression in mammalian oocytes. Biol Reprod (2012) 1.04
The expression of inhibin beta B is high in human adipocytes, reduced by weight loss, and correlates to factors implicated in metabolic disease. Biochem Biophys Res Commun (2006) 1.03
Localization of the activin signal transduction components in normal human ovarian follicles: implications for autocrine and paracrine signaling in the ovary. J Clin Endocrinol Metab (2002) 1.03
Hydrogel network design using multifunctional macromers to coordinate tissue maturation in ovarian follicle culture. Biomaterials (2011) 1.03
Murine granulosa cell morphology and function are regulated by a synthetic Arg-Gly-Asp matrix. Mol Cell Endocrinol (2003) 1.03
A macrophage and theca cell-enriched stromal cell population influences growth and survival of immature murine follicles in vitro. Reproduction (2011) 1.02
Properties of inhibin binding to betaglycan, InhBP/p120 and the activin type II receptors. Mol Cell Endocrinol (2002) 1.02
Fibrin encapsulation and vascular endothelial growth factor delivery promotes ovarian graft survival in mice. Tissue Eng Part A (2011) 1.02
Rational design, synthesis, and biological evaluation of progesterone-modified MRI contrast agents. Chem Biol (2007) 1.01
Using decision trees to enhance interdisciplinary team work: the case of oncofertility. J Assist Reprod Genet (2010) 1.00
The oncofertility saturday academy: a paradigm to expand the educational opportunities and ambitions of high school girls. Cancer Treat Res (2010) 0.99
Structural and biophysical coupling of heparin and activin binding to follistatin isoform functions. J Biol Chem (2007) 0.97
Improved fertility preservation care for male patients with cancer after establishment of formalized oncofertility program. J Urol (2012) 0.96
The development of a mouse model of ovarian endosalpingiosis. Endocrinology (2005) 0.96
Oncofertility consortium consensus statement: guidelines for ovarian tissue cryopreservation. Cancer Treat Res (2007) 0.95
Future Directions in Oncofertility and Fertility Preservation: A Report from the 2011 Oncofertility Consortium Conference. J Adolesc Young Adult Oncol (2013) 0.95
N-linked oligosaccharides direct the differential assembly and secretion of inhibin alpha- and betaA-subunit dimers. Mol Endocrinol (2007) 0.94
The role of activin A and Akt/GSK signaling in ovarian tumor biology. Endocrinology (2008) 0.94
Beta A versus beta B: is it merely a matter of expression? Mol Cell Endocrinol (2004) 0.94
Normal reproductive function in InhBP/p120-deficient mice. Mol Cell Biol (2003) 0.93
The Gynecologist Has a Unique Role in Providing Oncofertility Care to Young Cancer Patients. US Obstet Gynecol (2011) 0.93
Bioengineering the ovarian follicle microenvironment. Annu Rev Biomed Eng (2014) 0.92
Sex and sensitivity: the continued need for sex-based biomedical research and implementation. Womens Health (Lond Engl) (2010) 0.92
Inhibin at 90: from discovery to clinical application, a historical review. Endocr Rev (2014) 0.91
Preserving fertility during cancer treatment. Nat Med (2009) 0.91
Betaglycan localization in the female rat pituitary: implications for the regulation of follicle-stimulating hormone by inhibin. Endocrinology (2003) 0.91
The interactions between the stimulatory effect of follicle-stimulating hormone and the inhibitory effect of estrogen on mouse primordial folliculogenesis. Biol Reprod (2009) 0.90
Incorporating fertility preservation into the care of young oncology patients. Cancer (2011) 0.90
A steroid-conjugated contrast agent for magnetic resonance imaging of cell signaling. J Am Chem Soc (2005) 0.90
Primate follicular development and oocyte maturation in vitro. Adv Exp Med Biol (2013) 0.89
Smad3 and Pitx2 cooperate in stimulation of FSHbeta gene transcription. Mol Cell Endocrinol (2007) 0.89
Gene expression in mouse ovarian follicle development in vivo versus an ex vivo alginate culture system. Reproduction (2011) 0.89
Molecular biology of inhibin action. Semin Reprod Med (2004) 0.89
Embryonic fibroblasts enable the culture of primary ovarian follicles within alginate hydrogels. Tissue Eng Part A (2012) 0.89
Zinc maintains prophase I arrest in mouse oocytes through regulation of the MOS-MAPK pathway. Biol Reprod (2012) 0.89
Alginate encapsulation supports the growth and differentiation of human primordial follicles within ovarian cortical tissue. J Assist Reprod Genet (2014) 0.88
Activin and estrogen crosstalk regulates transcription in human breast cancer cells. Endocr Relat Cancer (2007) 0.88
Bioengineering and the ovarian follicle. Cancer Treat Res (2007) 0.88
Nano-encapsulation of arsenic trioxide enhances efficacy against murine lymphoma model while minimizing its impact on ovarian reserve in vitro and in vivo. PLoS One (2013) 0.88
Noninvasive index of cryorecovery and growth potential for human follicles in vitro. Biol Reprod (2010) 0.88
Cell-specificity of transforming growth factor-beta response is dictated by receptor bioavailability. J Mol Endocrinol (2006) 0.87
Localization of activin and inhibin subunits, receptors and SMADs in the mouse mammary gland. Mol Cell Endocrinol (2003) 0.87
An activin/furin regulatory loop modulates the processing and secretion of inhibin alpha- and betaB-subunit dimers in pituitary gonadotrope cells. J Biol Chem (2008) 0.86
A method for ovarian follicle encapsulation and culture in a proteolytically degradable 3 dimensional system. J Vis Exp (2011) 0.86